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In vivo single-molecule imaging identifies altered
dynamics of calcium channels in dystrophin-mutant
C. elegans
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Single-molecule (SM) fluorescence microscopy allows the imaging of biomolecules in
cultured cells with a precision of a few nanometres but has yet to be implemented in
living adult animals. Here we used split-GFP (green fluorescent protein) fusions and
complementation-activated light microscopy (CALM) for subresolution imaging of individual
membrane proteins in live Caenorhabditis elegans (C. elegans). In vivo tissue-specific SM
tracking of transmembrane CD4 and voltage-dependent Ca2þ channels (VDCC) was
achieved with a precision of 30 nm within neuromuscular synapses and at the surface of
muscle cells in normal and dystrophin-mutant worms. Through diffusion analyses, we reveal
that dystrophin is involved in modulating the confinement of VDCC within sarcolemmal
membrane nanodomains in response to varying tonus of C. elegans body-wall muscles. CALM
expands the applications of SM imaging techniques beyond the petri dish and opens the
possibility to explore the molecular basis of homeostatic and pathological cellular processes
with subresolution precision, directly in live animals.
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I
n vivo fluorescence optical imaging is a powerful method to
characterize biological processes in live animal tissues. Yet, the
spatial precision at which these processes can be studied is
constrained by the fact that lateral resolutions in conventional
optical imaging are diffraction limited to B200 nm, a length
scale well above the nanometre-range interactions of most
biomolecules. In recent years, single-molecule (SM) fluorescence
microscopy techniques have provided means to study the
mobility and the function of biomolecules beyond this resolution
limit and with a precision of a few nanometres in cultured cells1.
Extending these techniques to live animal imaging could open
new avenues to examine the nanoscale behaviours of signaling
molecules under homeostatic control within live tissues and
during various developmental or pathogenic stages. Despite
previous efforts to track individual proteins and study protein–
protein interactions in embryos and early larval stages of
zebrafish2–4 and C. elegans nematodes5,6, SM fluorescence
imaging in intact adult animals remains highly challenging. In
vivo, tissue autofluorescence often results in poor signal-to-noise
ratio when attempting to detect individual fluorophores. This
issue can be addressed using high-contrast imaging techniques
such as highly inclined and laminated optical sheet excitation
(HILO)7 or selective plane illumination microscopy8,9; however,
advanced labelling methods are still required for site-specific SM
imaging. In particular, maintaining a nanomolar SM detection
regimen at subcellular locations in a live animal necessitates site-
directed and stochiometric labelling or detection of a few
biomolecules, despite their endogenous expression at levels
generally well above those required for SM studies.
SM detection regimes can be achieved using traditional
fluorescent protein (FP) fusions expressed in vivo; however,
it generally requires extensive and potentially toxic photobleach-
ing or alteration of protein expressions6. While this can be
avoided using fusions to photoactivable FPs10, the
photoactivation of a limited number of molecules at specific
organelles within live animal tissues is complicated by the fact
that FP mature before the fusions reach their final cellular
destination. An alternative is to label biomolecules post-
translationally and in a controllable manner by intravital
injection of synthetic fluorescence tags. However, most labelling
strategies demand micromolar concentrations of probes11, which
generally results in high levels of nonspecific binding to tissues
that cannot be washed-off. Moreover, residual non-targeted
probes circulating in the body of injected animals further hinder
SM imaging.
Recently, we introduced complementation-activated light
microscopy (CALM), a SM technique that allows nanometre-
precision imaging of individual biomolecules in living cells,
independently of their expression levels, at micromolar concen-
tration of fluorescent probes, and without the need to wash excess
probes12. In CALM, proteins of interest are fused to a dark, non-
mature split-GFP (green fluorescent protein) that lacks a 16
amino-acid b-strand. They are then fluorescently activated by
irreversible binding and complementation with synthetic peptide
sequences encoding the missing GFP b-strand (M3 peptides).
These small synthetic M3 peptides permit site-specific imaging
and tracking of individual fusion proteins by direct detection of
activated split-GFP (dCALM) or by single pair Fo¨rster resonance
energy transfer with fluorescently labelled M3 peptides (CALM-
spFRET)12. Here we applied CALM to tissue-specific imaging and
SM tracking of CD4 and voltage-dependent Ca2þ channel
(VDCC) membrane proteins in live adult C. elegans.
In C. elegans, VDCCs are located in the membrane of excitable
cells where they mediate the influx of extracellular Ca2þ in
response to depolarizing signals. They play an essential role for
electrochemical coupling in motor neurons by triggering
neurotransmitter release13 and for excitation–contraction
coupling in body-wall muscle cells where they elicit action
potentials14. A dysregulation of VDCC activity in dystrophin-
mutant C. elegans has recently been proposed to be a key factor
for the genesis of muscular dystrophy15; however, the channels’
location and membrane dynamics have not been studied in living
animals. Here we imaged and tracked individual VDCC at the
sarcolemma of muscle cells and within neuromuscular synapses
of normal and dystrophin-mutant C. elegans, using CALM.
We demonstrate that dystrophin is a load-bearing element and an
adaptive tension transducer involved in modulating the nanoscale
confinement of VDCC at the sarcolemma in response to changes
in muscle tonus. Our results illustrate that SM imaging and
tracking by CALM allows a phenotyping of diseases such as
muscular dystrophy with subresolution precision directly in intact
animals.
Results
Live tissue fluorescence imaging by CALM in C. elegans. To
explore the applications of dCALM and CALM-spFRET for live
tissue imaging, we first used a C. elegans strain expressing a
transmembrane CD4-split-GFP fusion under the muscle-specific
myo-3 promoter16 (Fig. 1a). Split-GFP complementary M3
peptides were microinjected at high concentration in the fluid-
filled pseudocoelomic cavity of live worms to allow their
distribution to all organs and the activation of CD4-split-GFP
on muscle cells (Fig. 1b and Supplementary Movie 1). Injected
M3 peptides rapidly triggered the specific GFP activation of CD4-
split-GFP on body-wall and vulval muscles (Fig. 1c and
Supplementary Fig. 1). When worms were injected with M3
peptides conjugated to an Alexa 647 fluorophore (M3-A647)-
specific CALM-spFRET imaging of CD4-split-GFP could also be
performed at 680 nm using only 488 nm excitation (Fig. 1d).
The large-excitation Stokes shift afforded by CALM-spFRET
prevented a direct excitation of residual M3-A647 nonspecifically
bound to other tissues and allowed muscle-specific near-infrared
imaging of CD4-split-GFP in living worms (Fig. 1d). FRET
signals on muscle cells were exclusively triggered by 1:1
stochiometric and irreversible binding of M3-A647 to CD4-
split-GFP, as confirmed by in vitro fluorescence correlation
spectroscopy (FCS) with recombinant split-GFP at picomolar
concentrations (Supplementary Fig. 2). Neither complementation
nor FRET was observed in transgenic worms injected with
unconjugated A647 (Fig. 1d).
Single-molecule tracking of CD4-split-GFP on muscle cells. In
CALM, the simple titration of complementary M3 peptides in
extracellular fluids permits a controlled SM imaging of split-GFP
fusion proteins specifically at the outer plasma membrane of cells
because the peptides do not activate intracellular split-GFP if they
are not injected directly in the cytoplasm12. To control the
activation rate of membrane CD4-split-GFP and achieve
continuous SM detection, we injected worms with low
concentrations of M3 peptides. SM dCALM imaging was
performed at the interface between the basal lamina and the
sarcolemma of body-wall muscles using 488 nm HILO excitation.
Under these conditions, activated CD4-split-GFP appearing as
individual GFP diffraction-limited spots (Fig. 2a,b and
Supplementary Movie 2) could be tracked by two-dimensional
(2D) Gaussian fitting of their point-spread function with a mean
localization accuracy of 32±8 nm (Fig. 2a,e and Supplementary
Fig. 3). Worms were additionally imaged by SM CALM-spFRET
after microinjection of M3-A647 peptides. At the sarcolemma,
individual complemented CD4-split-GFPs were identified as
diffraction-limited and colocalized diffusing spots that emitted
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in both GFP and A647 detection channels when excited at
488 nm (Fig. 2c). Single bleaching steps and blinking events where
both GFP and A647 fluorescence signals disappeared (Fig. 2c)
indicated an effective intramolecular spFRET between CD4-split-
GFP and M3-A647 and confirmed our ability to specifically
target, activate, detect and track individual transmembrane
CD4-split-GFP directly in C. elegans.
When analysing the diffusion of activated CD4-split-GFP
(6,193 trajectories, 21 muscle cells, five worms) by probability
distribution of the squared displacements (PDSD)17, three
diffusion regimes were identified (Fig. 2d). A first high-
mobility regime (10%) with a diffusion coefficient DCD4 1
¼ 1.14 10 1±5 10 3mm2s 1 showed free diffusion for a
length scale of up to
ffiffiffiffiffiffiffiffi
0:28
p
mm2 ¼ 530  20 nm (Fig. 2f). Two
additional low-mobility regimes with diffusion coefficients
DCD4 2¼ 2.34 10 2±3.4 10 3mm2s 1 (38%) and
DCD4 3¼ 3.31 10 3±8.0 10 4mm2s 1 (52%) were each
confined to membrane microdomains 420±20 and 110±4 nm in
diameter, respectively (Fig. 2f). The diffusion coefficients and
confinement sizes of these three regimes are consistent with the
generally heterogeneous and restricted diffusion of other
transmembrane proteins in cultured muscle cells18,19; however,
the largely confined and slow diffusive behaviours of
CD4-split-GFP in vivo likely stem from extracellular matrix
effects that are absent in cultured cells and from tracking at lower
temperatures. Importantly, these results demonstrate that the
nanoscale diffusion of individual membrane proteins and their
interactions with plasma membrane microdomains can be
quantitatively studied at the SM level in intact animals using
CALM.
CALM imaging of plasma membrane L-type VDCC in
C. elegans. To image VDCC by CALM, we fused split-GFP to the
N terminus of the a2d VDCC subunit (UNC-36) that associates
with both neuronal (UNC-2)20 and muscular (EGL-19)21 a1
subunits to form active membrane Ca2þ channels (Fig. 3a).
unc-36 null allele (e251) worms were rescued by reintroducing
UNC-36-split-GFP under the control of the endogenous unc-36
promoter via single copy insertion using MosSCI protocols22.
Mutant worms were also rescued with UNC-36-GFP to compare
CALM imaging with conventional GFP imaging of UNC-36. The
resulting integrated worms had fully rescued VDCC activities.
The phenotypic impairment of locomotion for UNC-36 mutation
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Figure 1 | Ensemble CALM imaging of CD4-split-GFP in C. elegans. (a) GFP immunofluorescence staining of C. elegans expressing CD4-split-GFP under a
muscle-specific promoter. CD4-split-GFP is detected in body-wall muscle somas, muscle arms (arrowheads, inset) and in vulval muscles (arrow).
Scale bars: 150 and 25 mm (inset). (b) Schematic of dCALM and CALM-spFRET by microinjection of synthetic M3 peptides in the pseudoceolomic cavity
of worms and activation of transmembrane CD4-split-GFP at muscle cell membranes. Adapted with permission from ref. 62 and from Z. F. Altun and D. H.
Hall (wormatlas.org). (c) Live worm dCALM confocal imaging of activated CD4-split-GFP at the surface of body-wall muscles. Scale bar: 100mm.
(d) CALM-spFRET confocal imaging of CD4-split-GFP in live C. elegans. Single excitation at 488 nm allows muscle-specific near-infrared imaging of
CD4-split-GFP (top) by eliminating interferences from nonspecifically bound peptides detected by dual 488 and 647 nm excitation (middle, arrowheads).
No complementation is observed when injecting worms with the unconjugated A647 dye (bottom). Scale bars: 25mm.
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was completely restored in thrashing assays and the conducting
activities of VDCC were identical to that of wild-type channels
(Fig. 3b,c and Supplementary Fig. 4).
In live worms, UNC-36-GFP localized in muscle cells and
motor neurons. Muscular UNC-36-GFPs were distributed at the
boundary of body-wall muscles and as a punctuated pattern at the
sarcolemma, while neuronal UNC-36-GFPs were distributed at
the nerve cords (Fig. 3d). To assess the effective plasma
membrane translocation of UNC-36 in these tissues, live worms
were microinjected with fluorescently labelled anti-GFP anti-
bodies. Anti-GFP staining was observed at the boundary of body-
wall muscle cells and as punctuates along the nerve cords but not
at the sarcolemma (Fig. 3d). The lack of sarcolemma staining was
likely because of the inability of large antibodies to access
crowded extracellular spaces at the interface between the
epidermal and body-wall muscle cells. Indeed, when we injected
much smaller M3 peptides and performed dCALM imaging, GFP
fluorescence from membrane-activated UNC-36-split-GFP was
specifically detected at the nerve cords and the muscle
sarcolemma (Fig. 3e). Activated GFP signals were weaker than
those of UNC-36-GFP suggesting a low, yet systematic, plasma
membrane translocation of muscular and neuronal UNC-36.
Activated UNC-36-split-GFP was localized at the membrane of
neuromuscular synapses based on colocalization with the
fluorescent acetylcholine receptor subunit UNC-29-tagRFP
(Fig. 3e). This position is consistent with the expected location
of VDCC in presynaptic active zones of motor neurons20.
UNC-36-split-GFP was also detected at the sarcolemma,
consistently with its interaction with the muscular EGL-19 a1
subunit of VDCC21. It localized in the A-band region, between
rows of dense bodies, the structures that anchor sarcomeric actin
filaments to the sarcolemma (Fig. 3f).
These results demonstrate that CALM affords specific in vivo
targeting and imaging of membrane Ca2þ channels within
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Figure 2 | Single-molecule tracking of CD4-split-GFP on muscle cells by dCALM and CALM-spFRET. (a) Individual activated CD4-split-GFP trajectories
at the plasma membrane of a dorsal muscle cell. Scale bar: 20mm. (b) Single frame image from the white square in a showing a 2D and 3D representation
of the GFP signal for two individual activated CD4-split-GFP (arrowheads). Scale bar: 2 mm. (c) CALM-spFRET imaging of an individual CD4-split-GFP
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Blinking (1.2 s) and single-step photobleaching (1.4 s) are observed. Diffraction-limited spots are intentionally expanded to facilitate visualization. Scale bar:
1mm. (d) Analysis of CD4-split-GFP diffusion by PDSD for time lag Dt¼ 100ms. The distribution is best described by a three-parameter fit indicative of
three regimes of diffusion for CD4-split-GFP at the sarcolemma. (e) Representative example of individual CD4-split-GFP trajectories. (f) Diffusion
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confined extracellular spaces at the basal lamina–muscle interface
and at neuromuscular synapses in C. elegans tissues.
Tracking of individual VDCC using CALM in C. elegans. We
then used SM dCALM and HILO excitation to track individual
VDCC in live worms. At the sarcolemma, activated VDCC
appeared as individual diffraction-limited fluorescent spots
during imaging (Supplementary Movie 3) and were distributed as
punctuates on muscle cells (Fig. 4a), in a pattern similar to that
observed using confocal microscopy. For each muscle cell,
hundreds of individual VDCC could be tracked with a precision
better than 30 nm (Supplementary Fig. 3). Muscle-wide trajectory
maps revealed a largely confined diffusion of the channels at the
sarcolemma (Fig. 4a). Individual VDCC tracked along the nerve
cords were also seen diffusing within neuromuscular synapses
when we overlapped UNC-36-split-GFP trajectory maps with
UNC-29-tagRFP images for worms co-expressing both fusion
proteins (Fig. 4b). The single emitter nature of both muscular and
neuronal VDCC was confirmed using fluorescence intensity time
trace analyses that displayed sudden activation, single-step
photobleaching and blinking events typical of SM detection
by dCALM12 (Fig. 4c). No activation of UNC-36-split-GFP
was observed when imaging non-injected integrated worms
(Supplementary Movie 4).
Muscle contraction modulates VDCC diffusion in nanodomains.
Taking advantage of the nanometre-precision imaging cap-
abilities of dCALM, we compared the nanoscale distribution and
diffusion of individual VDCC in resting body-wall muscles of
worms immobilized with polystyrene beads and in muscles
undergoing sustained contraction for worms anaesthetized with
the cholinergic agonist levamisole.
In resting muscles, two populations of slow and fast diffusing
VDCC undergoing confined or short-scale free diffusion were
identified at the sarcolemma (10,481 trajectories, 39 muscle cells,
six worms, Fig. 5a,b). Ensemble PDSD analyses revealed
that most channels (81%) diffused slowly (Dvdcc slow¼
1.22 10 3±1.2 10 4mm2s 1) in membrane nanodomains
82±2 nm in diameter (Fig. 5c,e and Supplementary Table 1).
The second VDCC population (19%) diffused 20-fold faster
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Figure 3 | Imaging of plasma membrane L-type VDCCs in live C. elegans by genetic engineering of UNC-36 fusion proteins. (a) Schematic of split-GFP
or full GFP fusion to UNC-36 (a2d subunit) and its association with the a1 and b subunits to form active transmembrane VDCC. (b) C. elegans thrashing
assays showing impaired motility in unc-36(e251) null allele mutant worms and functional rescue upon UNC-36-GFP and UNC-36-split-GFP gene insertion.
The mean number of body bending per min (±s.d.) was determined for n¼ 20 worms for all conditions (Welch‘s t-test, ***Po0.001). (c) Representative
traces of inward VDCC currents recorded from body muscle cells in response to depolarizing pulses from 60mV to  20, 0, þ 20 and þ40mV.
Compared with wild-type N2 worms (n¼8), the increase in activation midpoint potential (E0.5±s.e.m.) and time-to-peak kinetics of inward currents
(±s.e.m.) observed for unc-36 (e251) worms (n¼ 7) are restored to wild-type levels in UNC-36-GFP (n¼ 7) and UNC-36-split-GFP worms (n¼8; *E0.5:
ANOVA test P¼0.0141, Dunnett’s post test Po0.05 for unc-36(e251), P40.05 for others; *time-to-peak: Kruskal–Wallis test P¼0.0026, Dunn’s post test
Po0.05 for unc-36(e251), P40.05 for others). (d) Ensemble confocal fluorescence imaging of UNC-36-GFP and alexa-594 anti-GFP antibody in live
C. elegans. UNC-36-GFP is expressed in muscle cells and motor neurons at the nerve cords. Anti-GFP antibodies target only the edge of muscle cells and
the nerve cords. Scale bars: 5 mm. (e) Ensemble dCALM confocal imaging of UNC-36-split-GFP in live C. elegans expressing the acetylcholine receptor
subunit UNC-29-tagRFP. Membrane UNC-36-split-GFP is detected at the sarcolemma of muscle cell bodies (left) and within neuromuscular synapses
(red) along the nerve cords (arrowheads, right). Scale bars: 5 mm. (f) Immunofluorescence detection of GFP and of the beta-1 integrin PAT-3 showing
UNC-36-split-GFP localized in the A-band region of sarcomeres between rows of dense bodies (DBs). Scale bar: 5 mm.
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(Dvdcc fast¼ 2.22 10 2±1 10 3mm2s 1) and underwent
free diffusion for a length scale of 230±8 nm (Fig. 5c,e and
Supplementary Table 1), after which membrane obstacles induced
a subdiffusive behaviour. Both populations were independently
distributed at the sarcolemma (Supplementary Fig. 5), did not
change diffusion and diffused more slowly than CD4-split-GFP,
indicating that we imaged two behaviours of stably assembled
VDCC rather than a dynamic association of the glycosylpho-
sphatidylinositol-anchored UNC-36 (ref. 23) with the channels’
a1 subunit.
Additional Ripley’s K function and nearest-neighbour distance
analyses of the clustering and dispersion pattern of VDCC
nanodomains at the sarcolemma indicated that they were not
clustered but significantly more dispersed than expected for
complete spatial randomness, with a mean nearest-neighbour
distance of 769±339 nm (Fig. 5f and Supplementary Fig. 6). This
distance, below the 1-mm average width of sarcomeres in adult
C. elegans24 and above the width of one-half A-band (B350 nm),
suggests that individual sarcomere contains two VDCC
nanodomains. Because of the stochastic nature of CALM, we
could not accurately determine the exact number of VDCC per
nanodomain. However, when we injected worms with high
concentrations of M3 peptides to activate as many VDCCs as
possible at the sarcolemma, a count of single photobleaching
steps in individual nanodomains and additional quantitative
analyses of their fluorescence intensity distribution indicated that
some nanodomains comprise at least 10 VDCC (Supplementary
Fig. 7).
In muscles undergoing sustained contraction induced by
levamisol (36,325 trajectories, 62 muscle cells, 18 worms), slow
diffusing VDCC (91%) were nearly immobile with a 13-fold
decrease in lateral diffusion coefficient compared with resting
muscles (DLeva vdcc slow¼ 9.4 10 5±4 10 6mm2s 1,
Po0.001, Fig. 5d,e). No confinement was detected, indicative
of a strong reduction of the nanodomains’ size or the
near-immobilization of VDCC within intact nanodomains.
The diffusion of the fast VDCC population (9%) was
moderately reduced by 33% compared with resting muscles
(DLeva vdcc fast¼ 1.49 10 2±7 10 4mm2s 1, Po0.05);
however, the channels’ free diffusion distance was unchanged at
224±9 nm (Fig. 5d,e and Supplementary Table 1). Interestingly,
the nearest-neighbour distance between nanodomains signifi-
cantly decreased to 546±217 nm compared with resting muscles
(Po0.01, Fig. 5f and Supplementary Fig. 6). Transient reductions
in nanodomain interdistance were also observed during sporadic
muscle contractions of immobilized worms (Supplementary
Movie 5) suggesting that, under sustained or active contractions,
the sarcolemma undergoes a deformation that brings stable
VDCC nanodomains closer to each other in a process reminiscent
of sarcolemma festooning: a ballooning of the membrane between
dense bodies when muscles are shortened to less than their
resting length25.
Thus, the nanoscale mobility and the distribution of VDCC are
modulated by the tonic state of muscles. Our observations that a
large majority of VDCC are constrained in two nanodomains on
each sarcomere indicate that VDCC action potentials and
extracellular Ca2þ influx are spatially controlled in C. elegans
body-wall muscles and that they are further regulated, on the
nanometre scale, by a near-immobilization of the channels during
sustained cholinergic contractions. The nanoscale confinement of
most VDCCs and the effect of muscle contraction on their
diffusion suggest that this dominant population of Ca2þ
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channels is primarily involved in electromechanical coupling at
the sarcolemma.
Dystrophin impacts the nanoscale diffusion of sarcolemma
VDCC. At the sarcolemma, the interaction of dystrophin
with phospholipids, g-actin and the dystrophin-glycoprotein
complex26,27 could favour its role as a tension-sensing scaffold
and a load-bearing apparatus capable of transducing muscle
tension to membrane-embedded ion channels28,29. To investigate
the role of dystrophin as a potential modulator of VDCC lateral
mobility, we imaged dystrophin-deficient C. elegans dys-1(cx18)
mutant worms expressing UNC-36-split-GFP (Fig. 6a) by SM
dCALM.
At the macroscale there was no obvious difference in the
sarcolemma distribution of VDCC between dys-1 mutant and
normal worms (Supplementary Movie 6). However, clear changes
in sarcolemma scaffolding and fluidity were observed when we
tracked individual channels. In resting dys-1 mutant muscles
(17,273 trajectories, 32 muscle cells, five worms), the diffusion
coefficient of slow VDCC (85%) was not significantly different
from that of normal worms (Ddys-1 VDCC slow¼ 1.36 10 3
±2.0 10 4mm2s 1, P¼ 0.12, Fig. 6b,d); however, their
confinement size was reduced to 58±2 nm in diameter
(Supplementary Table 1), indicating that dystrophin is required
to maintain the confining area of VDCC nanodomains but not
their fluidity. The fast VDCC population (15%) diffused twofold
faster than in normal worms (Ddys-1 VDCC fast¼ 4.54 10 2±1.2 10 3mm2s 1, Po0.05, Fig. 6b,d), an increased
lateral mobility similar to that observed for other membrane
proteins in muscle cells lacking dystrophin30. As dystrophin
stiffens membranes that mimic the sarcolemma31, we attribute
this apparent higher sarcolemma fluidity to a loss of membrane
stiffness in dystrophin-mutant muscles. The free diffusion
distance of fast VDCC was increased to 303±10 nm compared
with resting normal muscles (Supplementary Table 1), suggesting
that dystrophin is also involved in maintaining sarcolemma
scaffolds outside VDCC nanodomains in body-wall muscles.
VDCC nanodomains remained well dispersed but with a nearest-
neighbour distance reduced to 606±273 nm compared with
normal worms (Po0.01, Fig. 6e and Supplementary Fig. 6). This
enhanced festooning of the sarcolemma and its reduced stiffness
are both consistent with dystrophin being a load-bearing element
capable of minimizing membrane strain by damping transverse
cytoplasmic forces that push towards the sarcolemma under
resting muscular tension. The smaller confinement area but
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Figure 5 | Diffusion analysis of individual VDCC at the sarcolemma of normal C. elegans worms expressing UNC-36-split-GFP. (a) Distribution of
diffusion coefficients for 10,481 VDCC trajectories (39 muscle cells, six worms) determined from individual MSD analysis and showing that two
populations of slow and fast diffusing channels co-exist at the sarcolemma of resting muscles. (b) Example of individual VDCC trajectories and the
evolution of their MSD over time. VDCC undergo either confined or short-scale free diffusion as determined using 2D diffusion models that best fit
the MSD (red). Scale bars: 200nm. (c) Ensemble probability distribution of the squared displacement (PDSD) analysis of VDCC diffusive behaviours
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unchanged diffusion coefficient of nanodomain-associated VDCC
further suggests that, in normal resting C. elegans muscles,
dystrophin does not bind directly to the channels but participates
in modulating the nanodomain confinement size and the
nanoscale spatial distribution of VDCC.
In dys-1 mutant worms anaesthetized with levamisole (40,068
trajectories, 33 muscle cells, six worms), the slow VDCC
population (92%), which was nearly immobile in normal
contracted muscles, displayed diffusive behaviours similar to
that observed in resting muscles lacking dystrophin, with a
confined diffusion within nanodomains 52±2 nm in diameter
(DLeva dys-1 VDCC slow¼ 9.8 10 4±1.2 10 4mm2s 1, P¼ 0.06,
Fig. 6c,d and Supplementary Table 1). The fast VDCC population
(8%) was less mobile by 35% compared with resting dys-1 mutant
muscles (DLeva dys-1 VDCC fast¼ 2.90 10 2±5 10 4
mm2s 1, Po0.05) and diffused freely over a nonsignificantly
changed length scale of 281±6 nm (Fig. 6c,d and Supplementary
Table 1). The nearest-neighbour distance between VDCC
nanodomains was similar to that of resting dystrophin-mutant
muscles at 628±257 nm (Fig. 6e and Supplementary Fig. 6). This
apparent lack of additional sarcolemma festooning and the
unchanged diffusive behaviour of nanodomain-associated VDCC
in dys-1 mutant muscles under sustained cholinergic stimulation
indicate that, in C. elegans, a functional dystrophin is required for
an effective modulation of VDCC nanoscale dynamics at the
sarcolemma during contractions.
Thus, dystrophin is a key scaffolding protein of the
sarcolemma where it plays a dual role as a load-bearing apparatus
and a tension transducer that has an impact on the nanoscale
diffusion of membrane-embedded VDCC in response to changes
in muscle tones. By showing that dystrophin is involved in
modulating the confinement size of VDCC that normally
generate action potentials and extracellular Ca2þ influx in
muscle cells, our SM dCALM data suggest that it participates,
directly or indirectly, in electromechanical coupling at the
membrane of body-wall muscles in live C. elegans.
Discussion
Using far-field fluorescence microscopy and CALM, we achieved
highly specific, SM sensitivity and nanometre accuracy imaging of
membrane proteins within confined tissue regions in intact living
C. elegans worms. We showed that microinjected CALM
complementary peptides diffusing throughout the body of
animals can activate fluorescent signals in engineered muscular
and neuronal tissues by targeting and binding irreversibly to cell
surface split-GFP fusion proteins. By tuning the concentration of
injected peptides, ensemble or continuous SM CALM imaging
could be performed by direct detection of activated split-GFP or
by spFRET with targeted near-infrared fluorophores regardless of
protein expression levels and of peptide nonspecific binding.
Compared with SM imaging with conventional FP6, CALM
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provides low-background and membrane-specific SM detection
without a need for photobleaching or alteration of protein
expression and thus permits SM studies at physiologically
relevant expression levels directly in live animals. While we
primarly focused on membrane protein imaging, similar SM
CALM detection of intracellular biomolecules may be achieved by
co-expressing split-FP fusions with genetically encoded M3
peptide sequences. Chemically or light-inducible transcriptional
elements might be used to control the expression of
complementary peptides and maintain an SM detection regime.
In principle, multiplex in vivo CALM imaging can also be realized
with additional split-CFP and split-YFP fusions and by varying
the fluorophores employed for CALM-spFRET.
In C. elegans, we tracked thousands of individual transmem-
brane proteins and channels with subresolution precision and
quantitatively studied their diffusion in membrane micro- and
nanodomains directly in live adult animals. In contrast to
ensemble and diffusion-limited measurements by fluorescence
recovery after photobleaching or FCS, single-particle tracking by
CALM provides detailed analyses of protein locations and
subpopulation dynamics at the nanoscale even for slow diffusing
and confined membrane biomolecules. While our technique can
be implemented in any animal species amenable to fluorescence
imaging, C. elegans provides many advantages for in vivo SM
studies. Its optical transparency, simple anatomy, small size and
easy propagation facilitate sample preparation and peptide
injection for SM CALM. These advantages, combined with the
means to generate knock-in strains32,33 and the availability of
large bioresources of C. elegans mutants open the possibilities of
correlating the nanoscale behaviour of individual biomolecules
imaged by CALM with phenotypic changes occurring at various
developmental or disease stages, as illustrated by our study of
VDCC dynamics in normal and dystrophin-mutant adult worms.
In this study, we reveal that dystrophin is a load-bearing
scafolding protein of C. elegans body-wall muscles that not only
influences membrane stiffness but also tranduces muscle tension
to membrane-embeded VDCC. We show that, in response to
changing muscle tones, dystrophin participates in modulating the
nanoscale diffusion of two sarcolemmal populations of VDCC: a
majority VDCC fraction undergoing slow and confined diffusion
in ordered membrane nanodomains, and a minority fraction of
channels diffusing faster and more randomly in other parts of the
sarcolemma. As observed for comparable Ca2þ channels in
cardiac myocytes34, the different diffusion characteristics and
locations of these two VDCC populations suggest that they might
play distinct roles for extracellular Ca2þ signalling on body-wall
muscles. The fact that muscle contractions and the lack of
functional dystrophin primarily influence nanodomain-associated
VDCC implies that this subpopulation of Ca2þ channels and
dystrophin itself are likely involved in electromechanical coupling
in C. elegans, a process that requires precise spatial and temporal
controls of Ca2þ influx in animal muscular tissues. The smaller,
faster and more randomly distributed diffusing population of
VDCC might regulate other Ca2þ -dependent cellular processes
in muscle cells.
The exact nature of VDCC nanodomains remains to be
determined. While caveolae have been proposed to be sites of
VDCC confinement in mammalian muscle cells35,36, there is as
yet no evidence of caveolae formation at the sarcolemma of
C. elegans, despite the expression of two caveolin isoforms37,38.
Rather than caveolae, flat caveolin scaffolds39 or membrane
rafts40 are potential nanodomains that could confine VDCC
and induce their slow diffusion. Many C. elegans glyco-
sylphosphatidylinositol-anchored proteins, such as UNC-36,
co-fraction with caveolin in detergent-resistant membranes41
and in mammalian cells, a2d subunits partition with other
VDCC subunits in lipid rafts42. In cells, these membrane domains
can slow down the lateral diffusion of proteins by a 10- to 20-fold
ratio18,43. Our observations that the diffusion of VDCC inside or
outside nanodomains differ by a comparable ratio suggest that
they might be confined by similar raft-like domains at the
sarcolemma.
We speculate that the confined diffusion of VDCC in
sarcolemmal nanodomains is important for normal muscle
functions in C. elegans. The confinement of VDCC and their
near-immobilization during contractions in normal body-wall
muscles might amplify small extracellular Ca2þ flux from action
potentials into high local Ca2þ concentrations by nanodomain
Ca2þ boosting44. This nanometre-scale localization of VDCC
Ca2þ loads could reduce cross-talks between intracellular Ca2þ
sources and increase the opening probability of Ca2þ -dependent
ryanodine/UNC-68 receptors in the closely apposed sarcoplasmic
reticulum45 to potentiate muscle contractions46,47. The impaired
modulation of VDCC confinement observed here in dystrophin-
mutant muscles might additionally have an impact on
nanodomain coupling between VDCC and SLO-1 current
rectifying BK channels48,49 which, when defective, increases the
excitability of muscle cells15 and induces the hyper-contracted
phenotype of dys-1(cx18) worms50. Overall, it appears that
dystrophin plays a key role for the nanoscale modulation of
VDCC dynamics at the sarcolemma in C. elegans body-wall
muscle cells. Such a function was not anticipated based on
conventional imaging but might participate to the impairment of
Ca2þ homeostasis and of normal muscle function in Duchenne
muscular dystrophy51,52.
In conclusion, SM CALM imaging opens new avenues to
explore the basic principles of homeostatic controls and the
molecular basis of diseases at the nanometre scale in intact animal
models by providing subresolution localization of individual
membrane proteins and unprecedented insights into their
diffusive behaviours within live tissues.
Methods
C. elegans strains. C. elegans strains were maintained on NGM agar plates at
20 C on Escherichia coli OP50 lawns. N2 Bristol wild-type worms, CD4-split-GFP
(kyEx1940[Pmyo-3::SL2::GFP1-10-CD4; Podr-1::SL2::DsRed]) worms a kind gift
of Dr Cornelia Bargmann, strain EG4322 (ttTi5605II; unc-119(ed9)III) and
unc-36(e251) worms from the Caenorhabditis Genetics Center, dys-1(cx18) worms
a kind gift from Dr Kathrin Gieseler, UNC-36-GFP (krSi3[UNC-36::GFP]; e251)
worms, UNC-36-split-GFP (krSi6[UNC-36::GFP 1-10]; e251) worms, UNC-36-
split-GFP dystrophin-mutant (krSi6[UNC-36::GFP 1-10]; e251; cx18) worms and
UNC-36-split-GFP/UNC-29-tagRFP (krSi6[UNC-36::GFP 1-10]; kr208(unc-29::
tagRFP); e251) worms were used in this study.
Plasmid construction and C. elegans genetics. UNC-36-split-GFP was obtained
by NheI and SacI insertion of the split-GFP-coding sequence (GFP 1–10) after the
signal peptide sequence in unc-36 cDNA20 by PCR fusion. A synthetic C. elegans
intron was also introduced upstream of GFP 1–10 to improve transgene expression.
This transgene sequence was inserted in a pCFJ151 vector backbone (Addgene) to
create the targeting vector pHZ043 and generate integrated animals by direct
insertion on chromosome II using MosSCI protocols22. An EGFP sequence was
fused to UNC-36 cDNA using the same approach, resulting in targeting vector
pHZ025.
For MosSCI experiments, a mixture of plasmids including the targeting vectors
pHZ043 or pHZ025 at 50 ng ml 1, the Mos transposase expression vector pJL43.1
at 50 ng ml 1 and the transformation markers Pmyo-3::GFP and Prab-3::GFP each
at 10 ng ml 1 were co-injected in worm strain EG4322.MosSCI insertion progenies
were screened by restoration of locomotion phenotypes and absence of
transformation markers. MosSCI insertion was verified using PCR. MosSCI worms
were then crossed with unc-36 null allele (e251) mutant worms to generate
UNC-36-split-GFP and UNC-36-GFP worms. UNC-36-split-GFP worms were
further crossed with a worm strain expressing the postsynaptic acetylcholine
receptor fused to a red fluorescent protein (UNC-29-tagRFP) to generate worms
dually expressing UNC-36-split-GFP/UNC-29-tagRFP. UNC-36-split-GFP worms
were also crossed with dystrophin-deficient dys-1(cx18) mutant worms to generate
dystrophin-mutant worms expressing UNC-36-split-GFP. All crosses were verified
using PCR.
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C. elegans phenotyping. Effective rescue of VDCC activity by integrated
expression of UNC-36-GFP and UNC-36-split-GFP was verified in thrashing
assays where 20 adult worms were transferred separately in a drop of M9 medium
at 20 C and thrashes were counted in 1-min intervals after 2min recovery. Data
are reported as the mean number of body bends per min±s.d. of the mean.
Statistically significant differences are estimated by a Welch two sample t-test.
Electrophysiology. Following microdissection of C. elegans, electrophysiological
recordings of membrane currents and potentials were performed in the whole-cell
configuration using an RK-400 patch-clamp amplifier (Bio-Logic)53. Acquisition
and command voltage were controlled using the pClamp9 software driving a
1322A Digidata (Molecular Devices). Data were analysed and graphed using Origin
software (OriginLab). The resistance of recording pipettes ranged between 2.5 and
2.8MO. Recordings were performed after 1min dialysis only on cells exhibiting
resistances above 800MO. Capacitance and resistance were not compensated.
The bath solution contained 140mM Tetraethylammonium chloride (TEACl),
6mM CaCl2, 5mM MgCl2, 3mM 4-Aminopyridine (4-AP), 10mM Hepes and
sucrose at 337mosm l 1 (pH 7.2). The pipette solution contained 140mM CsCl,
5mM TEACl, 5mM EGTA, 5mM Hepes, 4mM MgATP and sucrose at
328mosm l 1 (pH 7.2). The membrane potential was hold at  60mV, and
currents were recorded by applying 200-ms voltage steps from  70 to þ 70mV
with 10-mV increments. Leak currents were subtracted from all recordings.
Current–voltage relationships for N2 wild-type (n¼ 8), unc-36(e251) (n¼ 7),
UNC-36-GFP (n¼ 7) and UNC-36-split-GFP (n¼ 8) worms were established by
measuring the currents at the peak of the current and were fitted with the following
equation:
I vð Þ ¼ Gmax vVrevð Þ
1þ e
V0:5  vð Þ
k
  ð1Þ
where I(v) is the measured density of current, v the test voltage pulse, Gmax the
maximum conductance, Vrev the reversal potential, V0.5 the half-activation voltage
and k the steepness factor. Potentials of half-activation, E0.5 were obtained by
fitting, for each muscle cell, the current–voltage relationships of the inward
currents measured at the peak of the currents by equation (1). Time-to-peak kinetic
was measured for the maximal current traces (þ 20mV). The mean E0.5 and the
mean time-to-peak values are reported with error bars representing the s.e.m.
All chemicals were obtained from Sigma-Aldrich and all experiments were
performed at room temperature.
Immunohistochemistry. Mix-stage worms were freeze-fractured and fixed in
methanol/acetone according to freeze fracture protocols54; however, only adult
worms were imaged. For immunodetection of split-GFP fusion proteins, primary
rabbit anti-GFP antibodies (Invitrogen A11122, dilution 1/500) and secondary
polyclonal goat anti-rabbit Alexa-488-conjugated antibodies (Invitrogen A11008,
dilution 1/800) were used. For immunostaining of dense bodies, mouse MH25
antibodies against PAT-3 b-integrin55 (dilution 1/200) and secondary polyclonal
goat anti-mouse antibodies conjugated to Cy3 (Invitrogen A10521, dilution 1/500)
were used. For immunostaining of dystrophin, mouse monoclonal antibodies
against C. elegans dystrophin (BioTem 1H7-1B3-2C7-3F5, dilution 1/200),
a kind gift from Dr Kathrin Gieseler, and secondary polyclonal goat anti-mouse
antibodies conjugated to Cy3 (dilution 1/500) were used.
Worm microinjection. Worms were placed on dried 2% agarose injection pads in
a drop of mineral oil (Sigma, H8898) and were forced to adhere to the pads by
gentle brushing of the animal body. For ensemble dCALM and CALM-spFRET
imaging, purified synthetic complementary M3-biotin and M3-A647 peptides12
were diluted in PBS at concentrations of 5mM and 200 mM, respectively, before
being microinjected into the worms pseudoceolomic cavity in the head region of
the animals using a microinjector (Femtojet, Eppendorf) and FemtotipII
microinjection capillaries. Worms were microinjected in three to five steps of 0.3 s
with a few hundreds of femtolitres of the peptide solutions. Worms were allowed to
recover in an M9 drop on NGM plates at 15 C for 1 h and were then transferred to
20 C for at least 3 h before imaging. For SM dCALM and SM CALM-spFRET
of CD4-split-GFP, microinjections were performed with M3-biotin and M3-A647
peptide concentrations reduced to 200 and 20 mM, respectively, and worms’
recovery times were limited to 30–60min before imaging. For SM dCALM of
VDCC, worms were injected with higher M3-biotin concentrations than for SM
dCALM of CD4-split-GFP and longer recovery times were employed to
compensate for the low endogenous membrane expression of UNC-36-split-GFP.
M3-biotin peptides at 1mM were microinjected and worms were allowed to
recover for 3–12 h at 15 C before imaging. For in vivo membrane staining of
UNC-36-GFP, anti-GFP Alexa-594 antibodies (Invitrogen A-21312) were diluted
200-fold in injection buffer (20mM K2HPO4, 3mM Kþ citrate, 2% PEG 3000,
pH¼ 7.4) and were injected into the pseudocoelomic cavity56 in the head region
before recovery in an M9 drop on a NGM plate at 20 C for 3–6 h and imaging.
Ensemble microscopy imaging. Ensemble GFP, dCALM and CALM-spFRET
imaging of live worms were performed on a confocal Leica TCS SP5AOBS
microscope or a Leica DM5000B microscope equipped with a CSU10 spinning disc
confocal scanner system (Yokogawa). Appropriate laser excitation wavelengths and
emission filtering were used to image GFP and activated split-GFP fusions (488 nm
excitation), anti-GFP antibodies or UNC-29-tagRFP (561 nm excitation) and
M3-A647 peptides (633 nm excitation). FRET from complemented CD4-split-GFP
to M3-A647 was detected by single laser excitation at 488 nm and simultaneous
detection in the GFP and the A647 emission channels. Live worms were anaes-
thetized with 0.2% sodium azide or 50mM muscimol before being mounted
between 2% agarose pads and microscope coverslips for imaging. Freeze-fractured
and immunostained worms were imaged on the same microscopes, except for
immunostained CD4-split-GFP worms that were imaged by wide-field
epifluorescence.
Single-molecule microscopy imaging. SM dCALM and SM CALM-spFRET of
CD4-split-GFP in live worms were performed on an inverted IX70 Olympus
microscope equipped with custom-built total internal reflection (TIR) and highly
incline and laminated optical (HILO) elements, a  100 1.45 NA objective, a DV2
dual-view system (Photometrics), a QuantEM:512SC EMCCD (Photometrics)
and appropriated filters12. SM dCALM imaging of VDCC and simultaneous
dual-colour imaging of UNC-29-tagRFP was performed on an inverted Nikon
Eclipse Ti-E microscope equipped with TIR and HILO optics, 488, 561 and 647 nm
fibre-coupled excitation lasers, a  100 1.49 NA objective, a two-camera imaging
splitter (Andor) and two iXon EMCCD cameras (Andor). A multiband pass
ZET405/488/561/647x excitation filter (Chroma), a quad-band ZT 405/488/561/
647 dichroic mirror (Chroma), an emission splitting FF560-FDi01 dichroic mirror
(Semrock) and two emission filters at 525/50 nm (Semrock) and 600/50 nm
(Chroma) for GFP and tagRFP, respectively, were used.
HILO imaging of worms was achieved by moving circularly polarized laser
excitation beams away from the optical axis at the back-focal plan of the objectives
and at a position slightly off from the location normally required to obtain a critical
TIR angle. For both optical set-ups, the size of pixels in images was determined by
imaging a micrometre reticle and the alignment of emission channels was
performed by imaging 40-nm diameter TransFluoSphere beads (488/685 nm,
Invitrogen).
Non-anaesthetized worms (resting muscles) were deposited on 2% agarose pads
in a drop of M9 containing 0.1 mm polystyrene beads at 2.5% per volume
(Polyscience) and were mounted with a microscope coverslip57. Tracking was
only performed in-between sporadic muscle contractions. Worms anaesthetized
with levamisole (contracted muscles) were first deposited in a drop of 1mM
levamisole (Sigma) for 10–15min before being mounted in levamisole between
2% agarose pads and coverslips. In each worm, multiple muscle cells were
imaged at room temperature by continuous laser excitation and with camera
acquisition rates at 100ms per frame for CD4-split-GFP and 80ms per frame
for VDCC.
Tracking and diffusion analyses. SM tracking and diffusion analyses were
performed using SlimFast, a single-particle detection and tracking software written
in Matlab and based on multiple-target tracing algorithms58, which was generously
provided by Christian Ritcher and Jacob Piehler. We used parallel Matlab on CPU
clusters to localize, track and perform diffusion analysis on tens of thousands of
individual split-GFP fusions in multiple worms. SM tracking in dCALM movies
was performed by 2D Gaussian fitting of the point-spread function for each
activated CD4-split-GFP or VDCC in each frame. The mean localization
precision±s.d. for all individual fusion protein detected in CALM movies was
determined by the method of Thompson et al.59 Trajectories were built by linking
individual localized positions from one frame to the other, taking into account
blinking statistics and local particle densities. Only the trajectories with at least
three-step sizes were kept for ensemble and individual mean square displacement
(MSD) analyses and for probability distribution of the displacement squared
(PDSD) analyses.
For diffusion analyses, MSD and PDSD curves were computed17,43. For PDSD,
computations were performed on the first ten observation time lags, a number
sufficient to detect the confinement of CD4-split-GFP or VDCC on C. elegans
muscles under our imaging conditions. In brief, for the first ten time lags t, each
Pr2 curve was fitted with the general model:
P ~r2; t
  ¼ 1
Xn
i¼1
aiðtÞe r2=r2i ðtÞ
Xn
i¼1
aiðtÞ ¼ 1
ð2Þ
where the fitting coefficient ri2(t) and ai(t) are the square displacement and the
fraction corresponding to i numbers of diffusion regimes at each time lag t,
respectively. Pr2 distribution for CD4-split-GFP was best fitted with i¼ 3
diffusion regimes, while Pr2 distribution for VDCC were fitted with i¼ 2
regimes.
Error bars in MSD curves correspond to the s.e.m. Error bars for each ri2 in ri2(t)
curves were determined using r
2
iffiffiffi
N
p , where N represents the number of independent
data points used to build each probability distribution functions17,60.
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Diffusion coefficients were obtained by fitting MSD or ri2(t) curves using:
(i) an anomalous diffusion model:
or24 ¼ 4Data ð3Þ
where a is the anomalous exponent and Da is the time-dependent diffusion
coefficient;
(ii) A free Brownian diffusion model with measurement error:
or24 ¼ 4Dtþ 4s2 ð4Þ
where s is the position error and D is the diffusion coefficient;
or (iii) a circularly confined diffusion model with measurement error:
or24 ¼ R2 1A1e
4A2Dt
R2
 
þ 4s2 ð5Þ
where R is the confinement radius, s is the position error, D is the diffusion
coefficient, A1¼ 0.99 and A2¼ 0.85 (ref. 43).
Fitting was performed using Origin software (OriginLab). When diffusion was
found to be anomalous over the first ten time lags on ri2(t) curves, the linear part of
the curves were fitted with the free Brownian diffusion model to assess short-scale
diffusion coefficients and free diffusion distances. To build the distribution of
diffusion coefficients for individual VDCC, the free Brownian diffusion model was
fitted over the first three points of each individual MSD. All the diffusion
coefficients D are reported in micrometre squared per second±s.d. of the fit value.
Significant differences between diffusion coefficients were determined using F-tests.
Intensity time trace analyses on individual VDCC were performed by
integrating the fluorescence intensity within a 3 3 pixel region centred on the
point-spread function of each activated VDCC and for the whole length of
acquired dCALM movies, including periods with no GFP signal before activation
and after photobleaching. Background correction was performed by subtracting the
fluorescence intensity at each time point from a similar 3 3 pixel region in the
immediate vicinity of each individual VDCC. The slight differences in intensity
between time traces are because of moderate variations in HILO excitation field
uniformity when imaging different muscle cells or nerve cords in worms.
Distribution pattern analyses of VDCC nanodomains. Ripley’s K function
analyses and nearest-neighbour distance measurements were performed with the
software SpPack61 after 2D Gaussian fitting of the nanodomain positions in sum
intensity projection images of SM dCALM movies.
Ripley’s K analyses with edge corrections were performed on muscle cells for
multiple regions of interest totaling 650–2,000 mm2 of the sarcolemma membrane
in multiple worms for each condition. 95% confidence intervals for complete
spatial randomness were obtained by averaging Monte Carlo simulations consisting
of 500 replicates in multiple regions of interest with areas and nanodomain seeding
numbers similar to that of the worm data.
For nearest-neighbour distance measurements, 1,100–2,500 nanodomains were
analysed for each condition and data are reported as the mean nearest-neighbour
distance in nanometre±s.e.m. A non-parametric Wilcoxon sign-rank statistical
test was performed to assess significant differences between data sets.
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